Omaira Molina

513 total citations
18 papers, 287 citations indexed

About

Omaira Molina is a scholar working on Neurology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Omaira Molina has authored 18 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 6 papers in Pathology and Forensic Medicine and 5 papers in Rheumatology. Recurrent topics in Omaira Molina's work include Multiple Sclerosis Research Studies (6 papers), Peripheral Neuropathies and Disorders (5 papers) and Sarcoma Diagnosis and Treatment (3 papers). Omaira Molina is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), Peripheral Neuropathies and Disorders (5 papers) and Sarcoma Diagnosis and Treatment (3 papers). Omaira Molina collaborates with scholars based in Venezuela, Argentina and Brazil. Omaira Molina's co-authors include Joaquín A. Peña, Cecilia Montiel‐Nava, Ibis Soto de Castillo, Vanessa Daccach Marques, Edgar Carnero Contentti, Pablo A. López, Amilton Antunes Barreira, Alejandro Caride, Verónica Tkachuk and Edgardo Cristiano and has published in prestigious journals such as Journal of Neurology, Multiple Sclerosis Journal and Spinal Cord.

In The Last Decade

Omaira Molina

16 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omaira Molina Venezuela 11 130 124 84 45 28 18 287
Reza Vosoughi Canada 9 107 0.8× 194 1.6× 55 0.7× 52 1.2× 6 0.2× 22 354
Daniela Alberti Italy 14 276 2.1× 133 1.1× 39 0.5× 67 1.5× 11 0.4× 21 431
Nuria García‐Barragán Spain 10 264 2.0× 197 1.6× 85 1.0× 37 0.8× 10 0.4× 20 392
Reid Longmuir United States 12 173 1.3× 44 0.4× 42 0.5× 63 1.4× 11 0.4× 26 398
Kathryn B. Holroyd United States 10 172 1.3× 108 0.9× 29 0.3× 60 1.3× 9 0.3× 31 322
Ai Muroi Japan 14 151 1.2× 64 0.5× 34 0.4× 56 1.2× 22 0.8× 41 446
B Anciones Spain 9 173 1.3× 47 0.4× 65 0.8× 34 0.8× 19 0.7× 28 331
Davood Fathi Iran 12 136 1.0× 80 0.6× 32 0.4× 18 0.4× 14 0.5× 26 304
Joseph A. Lopez United States 8 78 0.6× 82 0.7× 32 0.4× 80 1.8× 9 0.3× 14 341
Kerri Prain Australia 8 244 1.9× 99 0.8× 41 0.5× 31 0.7× 15 0.5× 16 330

Countries citing papers authored by Omaira Molina

Since Specialization
Citations

This map shows the geographic impact of Omaira Molina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omaira Molina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omaira Molina more than expected).

Fields of papers citing papers by Omaira Molina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omaira Molina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omaira Molina. The network helps show where Omaira Molina may publish in the future.

Co-authorship network of co-authors of Omaira Molina

This figure shows the co-authorship network connecting the top 25 collaborators of Omaira Molina. A scholar is included among the top collaborators of Omaira Molina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omaira Molina. Omaira Molina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pappolla, Agustín, Francisco Sánchez, Vanessa Daccach Marques, et al.. (2020). Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population. Multiple Sclerosis and Related Disorders. 42. 102049–102049. 7 indexed citations
2.
Contentti, Edgar Carnero, Vanessa Daccach Marques, Ibis Soto de Castillo, et al.. (2020). Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohort. Journal of Neurology. 267(5). 1260–1268. 40 indexed citations
3.
Contentti, Edgar Carnero, Vanessa Daccach Marques, Ibis Soto de Castillo, et al.. (2019). Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patients. Multiple Sclerosis Journal. 26(8). 945–954. 20 indexed citations
4.
Contentti, Edgar Carnero, Ibis Soto de Castillo, Vanessa Daccach Marques, et al.. (2018). Application of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of Latin American patients. Multiple Sclerosis and Related Disorders. 20. 109–114. 24 indexed citations
5.
Contentti, Edgar Carnero, Vanessa Daccach Marques, Ibis Soto de Castillo, et al.. (2018). Short-segment transverse myelitis lesions in a cohort of Latin American patients with neuromyelitis optica spectrum disorders. Spinal Cord. 56(10). 949–954. 12 indexed citations
6.
Contentti, Edgar Carnero, Vanessa Daccach Marques, Ibis Soto de Castillo, et al.. (2017). Frequency of brain MRI abnormalities in neuromyelitis optica spectrum disorder at presentation: A cohort of Latin American patients. Multiple Sclerosis and Related Disorders. 19. 73–78. 27 indexed citations
7.
Molina, Omaira, et al.. (2013). Alteraciones cognitivas en pacientes con la enfermedad de Parkinson. 14(5). 237–242.
8.
Molina, Omaira, et al.. (2006). Meningoencefalitis amebiana primaria: comunicacion de dos nuevos casos Venezolanos. Arquivos de Neuro-Psiquiatria. 64(4). 1043–1046. 10 indexed citations
9.
Cano, Clímaco, et al.. (2003). Increased Serum Malondialdehyde and Decreased Nitric Oxide Within 24 Hours of Thrombotic Stroke Onset. American Journal of Therapeutics. 10(6). 473–476. 1 indexed citations
10.
Peña, Joaquín A., et al.. (2002). Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham´s chorea: clinical follow-up of 18 patients. Arquivos de Neuro-Psiquiatria. 60(2B). 374–377. 53 indexed citations
11.
Peña, Joaquín A., et al.. (2001). Serial MRI findings in the Costa Rican variant of neuronal ceroid-lipofuscinosis. Pediatric Neurology. 25(1). 78–80. 16 indexed citations
13.
Peña, Joaquín A., et al.. (2000). Hallervorden-spatz Disease: Two New Early Childhood Onset Cases. Journal of Child Neurology. 15(1). 30–32. 5 indexed citations
14.
Molina, Omaira, et al.. (2000). [Causes of dementia in Maracaibo, Venezuela: a re-evaluation].. PubMed. 30(2). 115–7. 2 indexed citations
15.
Lopez, Julio, et al.. (1999). Intradural prepontine growth: Giant ecchordosis physaliphora or extraosseous chordoma?. Neuropathology. 19(3). 336–340. 1 indexed citations
16.
Molina, Omaira, et al.. (1999). Extraventricular cerebral anaplastic ependymomas. Surgical Neurology. 51(6). 630–635. 24 indexed citations
17.
Molina, Omaira, et al.. (1999). Intradural prepontine growth: Giant ecchordosis physaliphora or extraosseous chordoma?. Neuropathology. 19(3). 336–340. 30 indexed citations
18.
Rodríguez‐Pérez, Rosa, et al.. (1998). [Central nervous system infection by free-living amebas: report of 3 Venezuelan cases].. PubMed. 26(154). 1005–8. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026